Maynard Um
-
-
-
-
-
-
-
Novo Nordisk gets UK approval for daily Wegovy weight loss pill
-
-
-
-
-
-
-
Novo Nordisk targets two-thirds cut in drug launch times with AI
-
-
-
-
-
-
-
Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
-
-
-
-
-
-
-
Why Eli Lilly stock is down 3% today: FDA adverse event data explained
-
-
-
-
-
-
-
Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage
-
-
-
-
-
-
-
Novo Nordisk says Wegovy pill shows greater weight loss than Lilly rival
-
-
-
-
-
-
-
Should you buy the dip in Novo Nordisk stock? Wall Street analyst answers
-
420,552 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

